FoxO1 Mediates PTEN Suppression of Androgen Receptor N- and C-Terminal Interactions and Coactivator Recruitment
Abstract FoxO (mammalian forkhead subclass O) proteins are transcription factors acting downstream of the PTEN (phosphatase and tensin homolog deleted on chromosome 10) tumor suppressor. Their activity is negatively regulated by AKT-mediated phosphorylation. Our previous studies showed that the tran...
Saved in:
Published in | Molecular endocrinology (Baltimore, Md.) Vol. 23; no. 2; pp. 213 - 225 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Oxford University Press
01.02.2009
The Endocrine Society |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Abstract
FoxO (mammalian forkhead subclass O) proteins are transcription factors acting downstream of the PTEN (phosphatase and tensin homolog deleted on chromosome 10) tumor suppressor. Their activity is negatively regulated by AKT-mediated phosphorylation. Our previous studies showed that the transcriptional activity of the androgen receptor (AR) was inhibited by PTEN in an AKT-sensitive manner. Here, we report the repression of the activity of the full-length AR and its N-terminal domain by FoxO1 and the participation of FoxO1 in AR inhibition by PTEN. Ectopic expression of active FoxO1 decreased the transcriptional activity of AR as well as androgen-induced cell proliferation and production of prostate-specific antigen. FoxO1 knock down by RNA interference increased the transcriptional activity of the AR in PTEN-intact cells and relieved its inhibition by ectopic PTEN in PTEN-null cells. Mutational analysis revealed that FoxO1 fragment 150–655, which contains the forkhead box and C-terminal activation domain, was required for AR inhibition. Mammalian two-hybrid and glutathione-S-transferase pull-down assays demonstrated that the inhibition of AR activity by PTEN through FoxO1 involved the interference of androgen-induced interaction of the N- and C-termini of the AR and the recruitment of the p160 coactivators to its N terminus and to the androgen response elements of natural AR target genes. These studies reveal new mechanisms for the inhibition of AR activity by PTEN-FoxO axis and establish FoxO proteins as important nuclear factors that mediate the mutual antagonism between AR and PTEN tumor suppressor in prostate cancer cells. |
---|---|
AbstractList | FoxO (mammalian forkhead subclass O) proteins are transcription factors acting downstream of the PTEN (phosphatase and tensin homolog deleted on chromosome 10) tumor suppressor. Their activity is negatively regulated by AKT-mediated phosphorylation. Our previous studies showed that the transcriptional activity of the androgen receptor (AR) was inhibited by PTEN in an AKT-sensitive manner. Here, we report the repression of the activity of the full-length AR and its N-terminal domain by FoxO1 and the participation of FoxO1 in AR inhibition by PTEN. Ectopic expression of active FoxO1 decreased the transcriptional activity of AR as well as androgen-induced cell proliferation and production of prostate-specific antigen. FoxO1 knock down by RNA interference increased the transcriptional activity of the AR in PTEN-intact cells and relieved its inhibition by ectopic PTEN in PTEN-null cells. Mutational analysis revealed that FoxO1 fragment 150-655, which contains the forkhead box and C-terminal activation domain, was required for AR inhibition. Mammalian two-hybrid and glutathione-S-transferase pull-down assays demonstrated that the inhibition of AR activity by PTEN through FoxO1 involved the interference of androgen-induced interaction of the N- and C-termini of the AR and the recruitment of the p160 coactivators to its N terminus and to the androgen response elements of natural AR target genes. These studies reveal new mechanisms for the inhibition of AR activity by PTEN-FoxO axis and establish FoxO proteins as important nuclear factors that mediate the mutual antagonism between AR and PTEN tumor suppressor in prostate cancer cells. FoxO (mammalian forkhead subclass O) proteins are transcription factors acting downstream of the PTEN (phosphatase and tensin homolog deleted on chromosome 10) tumor suppressor. Their activity is negatively regulated by AKT-mediated phosphorylation. Our previous studies showed that the transcriptional activity of the androgen receptor (AR) was inhibited by PTEN in an AKT-sensitive manner. Here, we report the repression of the activity of the full-length AR and its N-terminal domain by FoxO1 and the participation of FoxO1 in AR inhibition by PTEN. Ectopic expression of active FoxO1 decreased the transcriptional activity of AR as well as androgen-induced cell proliferation and production of prostate-specific antigen. FoxO1 knock down by RNA interference increased the transcriptional activity of the AR in PTEN-intact cells and relieved its inhibition by ectopic PTEN in PTEN-null cells. Mutational analysis revealed that FoxO1 fragment 150–655, which contains the forkhead box and C-terminal activation domain, was required for AR inhibition. Mammalian two-hybrid and glutathione- S -transferase pull-down assays demonstrated that the inhibition of AR activity by PTEN through FoxO1 involved the interference of androgen-induced interaction of the N- and C-termini of the AR and the recruitment of the p160 coactivators to its N terminus and to the androgen response elements of natural AR target genes. These studies reveal new mechanisms for the inhibition of AR activity by PTEN-FoxO axis and establish FoxO proteins as important nuclear factors that mediate the mutual antagonism between AR and PTEN tumor suppressor in prostate cancer cells. The studies establish nuclear FoxO factors as mediators of the inhibition of AR N/C interaction and coactivator recruitment by the PTEN tumor suppressor. FoxO (mammalian forkhead subclass O) proteins are transcription factors acting downstream of the PTEN (phosphatase and tensin homolog deleted on chromosome 10) tumor suppressor. Their activity is negatively regulated by AKT-mediated phosphorylation. Our previous studies showed that the transcriptional activity of the androgen receptor (AR) was inhibited by PTEN in an AKT-sensitive manner. Here, we report the repression of the activity of the full-length AR and its N-terminal domain by FoxO1 and the participation of FoxO1 in AR inhibition by PTEN. Ectopic expression of active FoxO1 decreased the transcriptional activity of AR as well as androgen-induced cell proliferation and production of prostate-specific antigen. FoxO1 knock down by RNA interference increased the transcriptional activity of the AR in PTEN-intact cells and relieved its inhibition by ectopic PTEN in PTEN-null cells. Mutational analysis revealed that FoxO1 fragment 150-655, which contains the forkhead box and C-terminal activation domain, was required for AR inhibition. Mammalian two-hybrid and glutathione-S-transferase pull-down assays demonstrated that the inhibition of AR activity by PTEN through FoxO1 involved the interference of androgen-induced interaction of the N- and C-termini of the AR and the recruitment of the p160 coactivators to its N terminus and to the androgen response elements of natural AR target genes. These studies reveal new mechanisms for the inhibition of AR activity by PTEN-FoxO axis and establish FoxO proteins as important nuclear factors that mediate the mutual antagonism between AR and PTEN tumor suppressor in prostate cancer cells.FoxO (mammalian forkhead subclass O) proteins are transcription factors acting downstream of the PTEN (phosphatase and tensin homolog deleted on chromosome 10) tumor suppressor. Their activity is negatively regulated by AKT-mediated phosphorylation. Our previous studies showed that the transcriptional activity of the androgen receptor (AR) was inhibited by PTEN in an AKT-sensitive manner. Here, we report the repression of the activity of the full-length AR and its N-terminal domain by FoxO1 and the participation of FoxO1 in AR inhibition by PTEN. Ectopic expression of active FoxO1 decreased the transcriptional activity of AR as well as androgen-induced cell proliferation and production of prostate-specific antigen. FoxO1 knock down by RNA interference increased the transcriptional activity of the AR in PTEN-intact cells and relieved its inhibition by ectopic PTEN in PTEN-null cells. Mutational analysis revealed that FoxO1 fragment 150-655, which contains the forkhead box and C-terminal activation domain, was required for AR inhibition. Mammalian two-hybrid and glutathione-S-transferase pull-down assays demonstrated that the inhibition of AR activity by PTEN through FoxO1 involved the interference of androgen-induced interaction of the N- and C-termini of the AR and the recruitment of the p160 coactivators to its N terminus and to the androgen response elements of natural AR target genes. These studies reveal new mechanisms for the inhibition of AR activity by PTEN-FoxO axis and establish FoxO proteins as important nuclear factors that mediate the mutual antagonism between AR and PTEN tumor suppressor in prostate cancer cells. Abstract FoxO (mammalian forkhead subclass O) proteins are transcription factors acting downstream of the PTEN (phosphatase and tensin homolog deleted on chromosome 10) tumor suppressor. Their activity is negatively regulated by AKT-mediated phosphorylation. Our previous studies showed that the transcriptional activity of the androgen receptor (AR) was inhibited by PTEN in an AKT-sensitive manner. Here, we report the repression of the activity of the full-length AR and its N-terminal domain by FoxO1 and the participation of FoxO1 in AR inhibition by PTEN. Ectopic expression of active FoxO1 decreased the transcriptional activity of AR as well as androgen-induced cell proliferation and production of prostate-specific antigen. FoxO1 knock down by RNA interference increased the transcriptional activity of the AR in PTEN-intact cells and relieved its inhibition by ectopic PTEN in PTEN-null cells. Mutational analysis revealed that FoxO1 fragment 150–655, which contains the forkhead box and C-terminal activation domain, was required for AR inhibition. Mammalian two-hybrid and glutathione-S-transferase pull-down assays demonstrated that the inhibition of AR activity by PTEN through FoxO1 involved the interference of androgen-induced interaction of the N- and C-termini of the AR and the recruitment of the p160 coactivators to its N terminus and to the androgen response elements of natural AR target genes. These studies reveal new mechanisms for the inhibition of AR activity by PTEN-FoxO axis and establish FoxO proteins as important nuclear factors that mediate the mutual antagonism between AR and PTEN tumor suppressor in prostate cancer cells. |
Author | Nicosia, Santo V. Ma, Qiuping Jenster, Guido Bai, Wenlong Li, Pengfei Zhang, Xiaohong Fu, Wei |
Author_xml | – sequence: 1 givenname: Qiuping surname: Ma fullname: Ma, Qiuping organization: 1Departments of Pathology and Cell Biology (Q.M., W.F., P.L., S.V.N., X.Z., W.B.), Tampa, Florida 33612-4799 – sequence: 2 givenname: Wei surname: Fu fullname: Fu, Wei organization: 1Departments of Pathology and Cell Biology (Q.M., W.F., P.L., S.V.N., X.Z., W.B.), Tampa, Florida 33612-4799 – sequence: 3 givenname: Pengfei surname: Li fullname: Li, Pengfei organization: 1Departments of Pathology and Cell Biology (Q.M., W.F., P.L., S.V.N., X.Z., W.B.), Tampa, Florida 33612-4799 – sequence: 4 givenname: Santo V. surname: Nicosia fullname: Nicosia, Santo V. organization: 1Departments of Pathology and Cell Biology (Q.M., W.F., P.L., S.V.N., X.Z., W.B.), Tampa, Florida 33612-4799 – sequence: 5 givenname: Guido surname: Jenster fullname: Jenster, Guido organization: 5Department of Urology (G.J.), Josephine Nefkens Institute, Be362a, Erasmus MC, the Netherlands – sequence: 6 givenname: Xiaohong surname: Zhang fullname: Zhang, Xiaohong organization: 1Departments of Pathology and Cell Biology (Q.M., W.F., P.L., S.V.N., X.Z., W.B.), Tampa, Florida 33612-4799 – sequence: 7 givenname: Wenlong surname: Bai fullname: Bai, Wenlong email: wbai@health.usf.edu organization: 1Departments of Pathology and Cell Biology (Q.M., W.F., P.L., S.V.N., X.Z., W.B.), Tampa, Florida 33612-4799 |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/19074551$$D View this record in MEDLINE/PubMed |
BookMark | eNp1ks1vFSEUxYmpsa_VnWvDSjdOBYZhmI1J89Jqk9oafa4JMHcqZgZGYBr972V89TPpipD7O-eQezhCBz54QOgpJSeUUfJqghNGiKwI5e0DtKEd51XX0fYAbYiUspKSdIfoKKUvpCCNpI_QIe1Iy5uGblA4D9-uKX4HvdMZEn6_O7vCH5d5jpCSCx6HAZ_6PoYb8PgDWJhziPiqwtr3eFvtIE7O6xFf-AxR21wkaT8L6-1Wr3jRxcXlCXx-jB4Oekzw5O48Rp_Oz3bbt9Xl9ZuL7ellZTnluTJysNq0VA8Gas4so0b39UAM50LbWtjWdrLnPRUCGrBMdqampjOiA9tzLepj9HrvOy9mgt6W6KhHNUc36fhdBe3UvxPvPqubcKuY4EIwVgye3xnE8HWBlNXkkoVx1B7CkpQQsmlqXhfw2d9JvyN-7bgAL_eAjSGlCMMfhKi1QjWBWitUa4UFZ__h1mW9Lra80433iV7sRWGZ77P_-UPqH-1wrTo |
CitedBy_id | crossref_primary_10_3390_ijms25105302 crossref_primary_10_1007_s00403_019_01908_x crossref_primary_10_1111_j_1610_0387_2010_07344_x crossref_primary_10_1111_j_1365_2133_2010_09754_x crossref_primary_10_1186_s13046_024_03097_6 crossref_primary_10_1111_exd_12142 crossref_primary_10_1016_j_mce_2013_09_036 crossref_primary_10_1038_emboj_2011_328 crossref_primary_10_1111_j_1365_2133_2010_10033_x crossref_primary_10_4161_derm_15331 crossref_primary_10_1016_j_eururo_2014_10_027 crossref_primary_10_1177_1534735414534728 crossref_primary_10_1016_j_bone_2011_05_023 crossref_primary_10_4161_derm_19828 crossref_primary_10_1007_s00403_012_1265_x crossref_primary_10_1111_bjd_14409 crossref_primary_10_3390_biomedicines10081872 crossref_primary_10_1159_000375370 crossref_primary_10_1186_s12986_017_0212_4 crossref_primary_10_1002_pros_21162 crossref_primary_10_1242_dev_044560 crossref_primary_10_1186_s12951_023_01812_7 crossref_primary_10_1002_ijc_27973 crossref_primary_10_1111_exd_14277 crossref_primary_10_1016_j_stemcr_2015_01_018 crossref_primary_10_1111_iep_12460 crossref_primary_10_1111_exd_13787 crossref_primary_10_1530_JOE_10_0480 crossref_primary_10_1158_0008_5472_CAN_09_1504 crossref_primary_10_1016_j_mce_2011_03_026 crossref_primary_10_18632_oncotarget_260 crossref_primary_10_1172_JCI71545 crossref_primary_10_3390_cells10051219 crossref_primary_10_1002_pros_22649 crossref_primary_10_1016_j_exger_2012_03_020 crossref_primary_10_1007_s00018_010_0511_7 crossref_primary_10_1002_pros_22646 crossref_primary_10_1371_journal_pone_0072400 crossref_primary_10_1002_pros_22566 crossref_primary_10_1074_jbc_R109_075044 crossref_primary_10_1016_j_jdsct_2024_100017 |
Cites_doi | 10.1074/jbc.M704735200 10.1210/mend.16.4.0818 10.1074/jbc.M610447200 10.1093/jnci/91.22.1922 10.1093/carcin/18.6.1215 10.1016/S1535-6108(02)00086-7 10.1073/pnas.0437824100 10.1074/jbc.272.47.29821 10.1038/sj.onc.1209086 10.1016/S1097-2765(00)80303-2 10.1038/sj.onc.1203126 10.1210/me.2001-0316 10.1210/mend.13.3.0255 10.1074/jbc.270.13.7341 10.1210/mend-5-10-1396 10.1074/jbc.M104278200 10.1038/ncb1546 10.3322/canjclin.43.1.7 10.1210/jc.2002-021324 10.1074/jbc.M010226200 10.1016/S1097-2765(02)00471-9 10.1677/jme.0.0310169 10.1677/jme.0.0220313 10.1210/me.2004-0065 10.1128/MCB.23.1.104-118.2003 10.1074/jbc.M207509200 10.1074/jbc.270.50.29983 10.1210/me.2004-0190 10.1126/science.1086336 10.1128/MCB.19.9.6164 10.1158/0008-5472.CAN-06-4202 10.1093/genetics/139.4.1567 10.1016/S1535-6108(03)00215-0 10.1515/BC.2005.009 10.1073/pnas.96.5.2110 10.1126/science.1152257 10.1146/annurev.bi.63.070194.002315 10.1002/jcb.10653 10.1016/j.cell.2006.03.046 10.1210/mend.15.6.0647 10.1007/s00018-003-2309-3 10.1128/MCB.19.9.6085 10.1074/jbc.M204131200 10.1074/jbc.M002807200 10.1073/pnas.0602567103 10.1210/en.2003-0568 10.1016/j.cell.2006.12.029 10.1128/MCB.19.2.1182 10.1158/0008-5472.CAN-06-0411 |
ContentType | Journal Article |
Copyright | Copyright © 2009 by The Endocrine Society 2009 Copyright © 2009 by The Endocrine Society 2009 |
Copyright_xml | – notice: Copyright © 2009 by The Endocrine Society 2009 – notice: Copyright © 2009 by The Endocrine Society 2009 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM |
DOI | 10.1210/me.2008-0147 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Anatomy & Physiology |
EISSN | 1944-9917 |
EndPage | 225 |
ExternalDocumentID | PMC2646622 19074551 10_1210_me_2008_0147 10.1210/me.2008-0147 |
Genre | Research Support, U.S. Gov't, Non-P.H.S Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NCI NIH HHS grantid: CA93666 – fundername: NCI NIH HHS grantid: R01 CA111334 – fundername: NCI NIH HHS grantid: R01 CA093666 – fundername: NCI NIH HHS grantid: CA111334 |
GroupedDBID | --- -DZ .55 .XZ 08P 123 18M 29M 2WC 34G 354 39C 3O- 4.4 53G 5RS 5YH 8F7 AABZA AACZT AAPQZ AAPXW AARHZ AAUAY AAVAP ABJNI ABNHQ ABOCM ABPPZ ABPTD ABXVV ACGFO ACGFS ACUFI ADBBV ADGZP ADIYS ADQBN ADVEK AENEX AETEA AFFNX AFFZL AFOFC AFOSN AFXAL AGINJ AGUTN AJEEA ALMA_UNASSIGNED_HOLDINGS ATGXG BAWUL BAYMD BCRHZ C45 CS3 DIK DU5 E3Z EBS EJD F5P FLUFQ FOEOM GX1 H13 HF~ HZ~ H~9 IH2 KQ8 KSI KSN L7B M5~ NOMLY OAUYM OBH OFXIZ OHH OJZSN OK1 OPAEJ OVD P2P REU ROX ROZ TEORI TJX TR2 VVN W8F WOQ X7M XOL YBU YOC ZCA ZY1 0R~ AAFWJ AAYXX ABDFA ABEJV ABGNP ABVGC ADVOB AEMQT AHMMS ALXQX CITATION .GJ AAKAS ACFRR ACUTJ ACVCV ADZCM AGMDO APJGH AQKUS ASAOO ATDFG CGR CUY CVF ECM EIF MBLQV MBTAY NPM WHG X52 ZCG ZGI ZXP 7X8 5PM |
ID | FETCH-LOGICAL-c414t-b8fcab71afbe342c21bad3f0b446ac36c7c98d4d166e5ec289b31b9b69ecd4a63 |
ISSN | 0888-8809 |
IngestDate | Thu Aug 21 14:07:54 EDT 2025 Thu Jul 10 17:23:14 EDT 2025 Thu Apr 03 07:03:42 EDT 2025 Tue Jul 01 01:47:42 EDT 2025 Thu Apr 24 23:03:48 EDT 2025 Wed Sep 11 05:00:55 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c414t-b8fcab71afbe342c21bad3f0b446ac36c7c98d4d166e5ec289b31b9b69ecd4a63 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Address all correspondence and requests for reprints to: Wenlong Bai, Ph.D., Departments of Pathology and Cell Biology, University of South Florida, College of Medicine, 12901 Bruce B. Downs Boulevard, MDC 11, Tampa, Florida 33612-4799. E-mail: wbai@health.usf.edu. |
OpenAccessLink | https://academic.oup.com/mend/article-pdf/23/2/213/8941908/mend0213.pdf |
PMID | 19074551 |
PQID | 66855343 |
PQPubID | 23479 |
PageCount | 13 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_2646622 proquest_miscellaneous_66855343 pubmed_primary_19074551 crossref_primary_10_1210_me_2008_0147 crossref_citationtrail_10_1210_me_2008_0147 oup_primary_10_1210_me_2008-0147 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2009-02-01 |
PublicationDateYYYYMMDD | 2009-02-01 |
PublicationDate_xml | – month: 02 year: 2009 text: 2009-02-01 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Molecular endocrinology (Baltimore, Md.) |
PublicationTitleAlternate | Mol Endocrinol |
PublicationYear | 2009 |
Publisher | Oxford University Press The Endocrine Society |
Publisher_xml | – name: Oxford University Press – name: The Endocrine Society |
References | Fan (2019041200062926400_R24) 2007; 282 Hsu (2019041200062926400_R29) 2005; 19 Jiao (2019041200062926400_R40) 2007; 67 Li (2019041200062926400_R12) 2001; 276 Jenster (2019041200062926400_R44) 1995; 270 Boring (2019041200062926400_R1) 1993; 43 Shen (2019041200062926400_R28) 2005; 386 He (2019041200062926400_R4) 2000; 275 Paik (2019041200062926400_R41) 2007; 128 Nawaz (2019041200062926400_R42) 1999; 19 Louie (2019041200062926400_R47) 2003; 100 Langley (2019041200062926400_R5) 1995; 270 Gioeli (2019041200062926400_R36) 2002; 277 Kasper (2019041200062926400_R19) 1999; 22 Chang (2019041200062926400_R30) 2002; 16 Zhao (2019041200062926400_R18) 2001; 276 Larsen (2019041200062926400_R32) 1995; 139 Modur (2019041200062926400_R49) 2002; 277 Ma (2019041200062926400_R21) 1999; 19 Jenster (2019041200062926400_R3) 1991; 5 Dong (2019041200062926400_R23) 2006; 66 Ali (2019041200062926400_R9) 1999; 91 Dutertre (2019041200062926400_R45) 2003; 17 Ramaswamy (2019041200062926400_R20) 2002; 2 Reddy (2019041200062926400_R11) 2008; 319 Thompson (2019041200062926400_R26) 2001; 15 Nan (2019041200062926400_R35) 2003; 31 Lehtinen (2019041200062926400_R14) 2006; 125 Castrillon (2019041200062926400_R34) 2003; 301 Xin (2019041200062926400_R37) 2006; 103 Zhang (2019041200062926400_R17) 2004; 145 Wang (2019041200062926400_R39) 2003; 4 Bello (2019041200062926400_R16) 1997; 18 Hatta (2019041200062926400_R25) 2007; 282 Lee (2019041200062926400_R7) 2003; 60 Stambolic (2019041200062926400_R8) 1999; 18 Shang (2019041200062926400_R46) 2002; 9 Wissmann (2019041200062926400_R48) 2007; 9 Ikonen (2019041200062926400_R6) 1997; 272 Kemppainen (2019041200062926400_R31) 1999; 13 Powzaniuk (2019041200062926400_R43) 2004; 18 Greer (2019041200062926400_R10) 2005; 24 Li (2019041200062926400_R13) 2003; 23 Tsai (2019041200062926400_R2) 1994; 63 Ramaswamy (2019041200062926400_R15) 1999; 96 Taplin (2019041200062926400_R38) 2004; 91 Alen (2019041200062926400_R22) 1999; 19 Ghali (2019041200062926400_R27) 2003; 88 Ogg (2019041200062926400_R33) 1998; 2 10557100 - Oncogene. 1999 Nov 1;18(45):6094-103 8422609 - CA Cancer J Clin. 1993 Jan-Feb;43(1):7-26 18239123 - Science. 2008 Feb 1;319(5863):611-3 10454563 - Mol Cell Biol. 1999 Sep;19(9):6164-73 12855809 - Science. 2003 Jul 11;301(5630):215-8 12727974 - J Clin Endocrinol Metab. 2003 May;88(5):2185-93 14522255 - Cancer Cell. 2003 Sep;4(3):209-21 14500578 - Endocrinology. 2004 Jan;145(1):134-48 17616663 - Cancer Res. 2007 Jul 1;67(13):6083-91 12150827 - Cancer Cell. 2002 Jul;2(1):81-91 17202144 - J Biol Chem. 2007 Mar 9;282(10):7329-38 16751106 - Cell. 2006 Jun 2;125(5):987-1001 17923482 - J Biol Chem. 2007 Dec 7;282(49):35583-93 10051603 - Proc Natl Acad Sci U S A. 1999 Mar 2;96(5):2110-5 10816582 - J Biol Chem. 2000 Jul 28;275(30):22986-94 12015328 - J Biol Chem. 2002 Aug 9;277(32):29304-14 9214605 - Carcinogenesis. 1997 Jun;18(6):1215-23 9368054 - J Biol Chem. 1997 Nov 21;272(47):29821-8 10454556 - Mol Cell Biol. 1999 Sep;19(9):6085-97 17254969 - Cell. 2007 Jan 26;128(2):309-23 12589022 - Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2226-30 12351634 - J Biol Chem. 2002 Dec 6;277(49):47928-37 10564676 - J Natl Cancer Inst. 1999 Nov 17;91(22):1922-32 7706276 - J Biol Chem. 1995 Mar 31;270(13):7341-6 15514032 - Mol Endocrinol. 2005 Feb;19(2):350-61 10343290 - J Mol Endocrinol. 1999 Jun;22(3):313-25 10077001 - Mol Endocrinol. 1999 Mar;13(3):440-54 7789761 - Genetics. 1995 Apr;139(4):1567-83 12714702 - Mol Endocrinol. 2003 Jul;17(7):1296-314 11353774 - J Biol Chem. 2001 Jul 27;276(30):27907-12 16849544 - Cancer Res. 2006 Jul 15;66(14):6998-7006 12482965 - Mol Cell Biol. 2003 Jan;23(1):104-18 7979245 - Annu Rev Biochem. 1994;63:451-86 14504652 - Cell Mol Life Sci. 2003 Aug;60(8):1613-22 9885576 - Mol Cell. 1998 Dec;2(6):887-93 16682621 - Proc Natl Acad Sci U S A. 2006 May 16;103(20):7789-94 15843149 - Biol Chem. 2005 Jan;386(1):69-74 12914534 - J Mol Endocrinol. 2003 Aug;31(1):169-83 8530400 - J Biol Chem. 1995 Dec 15;270(50):29983-90 11278645 - J Biol Chem. 2001 Jun 8;276(23):20444-50 11923463 - Mol Endocrinol. 2002 Apr;16(4):647-60 9891052 - Mol Cell Biol. 1999 Feb;19(2):1182-9 11376111 - Mol Endocrinol. 2001 Jun;15(6):923-35 11931767 - Mol Cell. 2002 Mar;9(3):601-10 15131260 - Mol Endocrinol. 2004 Aug;18(8):2011-23 17277772 - Nat Cell Biol. 2007 Mar;9(3):347-53 14755679 - J Cell Biochem. 2004 Feb 15;91(3):483-90 16288288 - Oncogene. 2005 Nov 14;24(50):7410-25 1775129 - Mol Endocrinol. 1991 Oct;5(10):1396-404 |
References_xml | – volume: 282 start-page: 35583 year: 2007 ident: 2019041200062926400_R25 article-title: Chromatin opening and stable perturbation of core histone:DNA contacts by FoxO1. publication-title: J Biol Chem doi: 10.1074/jbc.M704735200 – volume: 16 start-page: 647 year: 2002 ident: 2019041200062926400_R30 article-title: Evaluation of ligand-dependent changes in AR structure using peptide probes. publication-title: Mol Endocrinol doi: 10.1210/mend.16.4.0818 – volume: 282 start-page: 7329 year: 2007 ident: 2019041200062926400_R24 article-title: Insulin-like growth factor 1/insulin signaling activates androgen signaling through direct interactions of Foxo1 with androgen receptor. publication-title: J Biol Chem doi: 10.1074/jbc.M610447200 – volume: 91 start-page: 1922 year: 1999 ident: 2019041200062926400_R9 article-title: Mutational spectra of PTEN/MMAC1 gene: a tumor suppressor with lipid phosphatase activity. publication-title: J Natl Cancer Inst doi: 10.1093/jnci/91.22.1922 – volume: 18 start-page: 1215 year: 1997 ident: 2019041200062926400_R16 article-title: Androgen responsive adult human prostatic epithelial cell lines immortalized by human papillomavirus 18. publication-title: Carcinogenesis doi: 10.1093/carcin/18.6.1215 – volume: 2 start-page: 81 year: 2002 ident: 2019041200062926400_R20 article-title: A novel mechanism of gene regulation and tumor suppression by the transcription factor FKHR. publication-title: Cancer Cell doi: 10.1016/S1535-6108(02)00086-7 – volume: 100 start-page: 2226 year: 2003 ident: 2019041200062926400_R47 article-title: Androgen-induced recruitment of RNA polymerase II to a nuclear receptor-p160 coactivator complex. publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.0437824100 – volume: 272 start-page: 29821 year: 1997 ident: 2019041200062926400_R6 article-title: Interaction between the amino- and carboxyl-terminal regions of the rat androgen receptor modulates transcriptional activity and is influenced by nuclear receptor coactivators. publication-title: J Biol Chem doi: 10.1074/jbc.272.47.29821 – volume: 24 start-page: 7410 year: 2005 ident: 2019041200062926400_R10 article-title: FOXO transcription factors at the interface between longevity and tumor suppression. publication-title: Oncogene doi: 10.1038/sj.onc.1209086 – volume: 2 start-page: 887 year: 1998 ident: 2019041200062926400_R33 article-title: The C. elegans PTEN homolog, DAF-18, acts in the insulin receptor-like metabolic signaling pathway. publication-title: Mol Cell doi: 10.1016/S1097-2765(00)80303-2 – volume: 18 start-page: 6094 year: 1999 ident: 2019041200062926400_R8 article-title: Modulation of cellular apoptotic potential: contributions to oncogenesis. publication-title: Oncogene doi: 10.1038/sj.onc.1203126 – volume: 17 start-page: 1296 year: 2003 ident: 2019041200062926400_R45 article-title: Ligand-independent interactions of p160/steroid receptor coactivators and CREB-binding protein (CBP) with estrogen receptor-α: regulation by phosphorylation sites in the A/B region depends on other receptor domains. publication-title: Mol Endocrinol doi: 10.1210/me.2001-0316 – volume: 13 start-page: 440 year: 1999 ident: 2019041200062926400_R31 article-title: Distinguishing androgen receptor agonists and antagonists: distinct mechanisms of activation by medroxyprogesterone acetate and dihydrotestosterone. publication-title: Mol Endocrinol doi: 10.1210/mend.13.3.0255 – volume: 270 start-page: 7341 year: 1995 ident: 2019041200062926400_R44 article-title: Identification of two transcription activation units in the N-terminal domain of the human androgen receptor. publication-title: J Biol Chem doi: 10.1074/jbc.270.13.7341 – volume: 5 start-page: 1396 year: 1991 ident: 2019041200062926400_R3 article-title: Domains of the human androgen receptor involved in steroid binding, transcriptional activation, and subcellular localization. publication-title: Mol Endocrinol doi: 10.1210/mend-5-10-1396 – volume: 276 start-page: 27907 year: 2001 ident: 2019041200062926400_R18 article-title: Forkhead homologue in rhabdomyosarcoma functions as a bifunctional nuclear receptor-interacting protein with both coactivator and corepressor functions. publication-title: J Biol Chem doi: 10.1074/jbc.M104278200 – volume: 9 start-page: 347 year: 2007 ident: 2019041200062926400_R48 article-title: Cooperative demethylation by JMJD2C and LSD1 promotes androgen receptor- dependent gene expression. publication-title: Nat Cell Biol doi: 10.1038/ncb1546 – volume: 43 start-page: 7 year: 1993 ident: 2019041200062926400_R1 article-title: Cancer statistics, 1993. publication-title: CA Cancer J Clin doi: 10.3322/canjclin.43.1.7 – volume: 88 start-page: 2185 year: 2003 ident: 2019041200062926400_R27 article-title: The use of androgen receptor amino/carboxyl-terminal interaction assays to investigate androgen receptor gene mutations in subjects with varying degrees of androgen insensitivity. publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2002-021324 – volume: 276 start-page: 20444 year: 2001 ident: 2019041200062926400_R12 article-title: Antagonism between PTEN/MMAC1/TEP-1 and androgen receptor in growth and apoptosis of prostatic cancer cells. publication-title: J Biol Chem doi: 10.1074/jbc.M010226200 – volume: 9 start-page: 601 year: 2002 ident: 2019041200062926400_R46 article-title: Formation of the androgen receptor transcription complex. publication-title: Mol Cell doi: 10.1016/S1097-2765(02)00471-9 – volume: 31 start-page: 169 year: 2003 ident: 2019041200062926400_R35 article-title: The PTEN tumor suppressor is a negative modulator of androgen receptor transcriptional activity. publication-title: J Mol Endocrinol doi: 10.1677/jme.0.0310169 – volume: 22 start-page: 313 year: 1999 ident: 2019041200062926400_R19 article-title: Selective activation of the probasin androgen-responsive region by steroid hormones. publication-title: J Mol Endocrinol doi: 10.1677/jme.0.0220313 – volume: 18 start-page: 2011 year: 2004 ident: 2019041200062926400_R43 article-title: The LATS2/KPM tumor suppressor is a negative regulator of the androgen receptor. publication-title: Mol Endocrinol doi: 10.1210/me.2004-0065 – volume: 23 start-page: 104 year: 2003 ident: 2019041200062926400_R13 article-title: AKT-independent protection of prostate cancer cells from apoptosis mediated through complex formation between the androgen receptor and FKHR. publication-title: Mol Cell Biol doi: 10.1128/MCB.23.1.104-118.2003 – volume: 277 start-page: 47928 year: 2002 ident: 2019041200062926400_R49 article-title: FOXO proteins regulate tumor necrosis factor-related apoptosis inducing ligand expression. Implications for PTEN mutation in prostate cancer. publication-title: J Biol Chem doi: 10.1074/jbc.M207509200 – volume: 270 start-page: 29983 year: 1995 ident: 2019041200062926400_R5 article-title: Evidence for an anti-parallel orientation of the ligand-activated human androgen receptor dimer. publication-title: J Biol Chem doi: 10.1074/jbc.270.50.29983 – volume: 19 start-page: 350 year: 2005 ident: 2019041200062926400_R29 article-title: Androgen receptor (AR) NH2- and COOH-terminal interactions result in the differential influences on the AR-mediated transactivation and cell growth. publication-title: Mol Endocrinol doi: 10.1210/me.2004-0190 – volume: 301 start-page: 215 year: 2003 ident: 2019041200062926400_R34 article-title: Suppression of ovarian follicle activation in mice by the transcription factor Foxo3a. publication-title: Science doi: 10.1126/science.1086336 – volume: 19 start-page: 6164 year: 1999 ident: 2019041200062926400_R21 article-title: Multiple signal input and output domains of the 160-kilodalton nuclear receptor coactivator proteins. publication-title: Mol Cell Biol doi: 10.1128/MCB.19.9.6164 – volume: 67 start-page: 6083 year: 2007 ident: 2019041200062926400_R40 article-title: Murine cell lines derived from Pten null prostate cancer show the critical role of PTEN in hormone refractory prostate cancer development. publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-06-4202 – volume: 139 start-page: 1567 year: 1995 ident: 2019041200062926400_R32 article-title: Genes that regulate both development and longevity in Caenorhabditis elegans. publication-title: Genetics doi: 10.1093/genetics/139.4.1567 – volume: 4 start-page: 209 year: 2003 ident: 2019041200062926400_R39 article-title: Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer. publication-title: Cancer Cell doi: 10.1016/S1535-6108(03)00215-0 – volume: 386 start-page: 69 year: 2005 ident: 2019041200062926400_R28 article-title: GRIP1 mediates the interaction between the amino- and carboxyl-termini of the androgen receptor. publication-title: Biol Chem doi: 10.1515/BC.2005.009 – volume: 96 start-page: 2110 year: 1999 ident: 2019041200062926400_R15 article-title: Regulation of G1 progression by the PTEN tumor suppressor protein is linked to inhibition of the phosphatidylinositol 3-kinase/Akt pathway. publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.96.5.2110 – volume: 319 start-page: 611 year: 2008 ident: 2019041200062926400_R11 article-title: Oocyte-specific deletion of Pten causes premature activation of the primordial follicle pool. publication-title: Science doi: 10.1126/science.1152257 – volume: 63 start-page: 451 year: 1994 ident: 2019041200062926400_R2 article-title: Molecular mechanisms of action of steroid/thyroid receptor superfamily members. publication-title: Annu Rev Biochem doi: 10.1146/annurev.bi.63.070194.002315 – volume: 91 start-page: 483 year: 2004 ident: 2019041200062926400_R38 article-title: Androgen receptor: a key molecule in the progression of prostate cancer to hormone independence. publication-title: J Cell Biochem doi: 10.1002/jcb.10653 – volume: 125 start-page: 987 year: 2006 ident: 2019041200062926400_R14 article-title: A conserved MST-FOXO signaling pathway mediates oxidative-stress responses and extends life span. publication-title: Cell doi: 10.1016/j.cell.2006.03.046 – volume: 15 start-page: 923 year: 2001 ident: 2019041200062926400_R26 article-title: Disrupted amino- and carboxyl-terminal interactions of the androgen receptor are linked to androgen insensitivity. publication-title: Mol Endocrinol doi: 10.1210/mend.15.6.0647 – volume: 60 start-page: 1613 year: 2003 ident: 2019041200062926400_R7 article-title: Recent advances in androgen receptor action. publication-title: Cell Mol Life Sci doi: 10.1007/s00018-003-2309-3 – volume: 19 start-page: 6085 year: 1999 ident: 2019041200062926400_R22 article-title: The androgen receptor amino-terminal domain plays a key role in p160 coactivator-stimulated gene transcription. publication-title: Mol Cell Biol doi: 10.1128/MCB.19.9.6085 – volume: 277 start-page: 29304 year: 2002 ident: 2019041200062926400_R36 article-title: Androgen receptor phosphorylation. Regulation and identification of the phosphorylation sites. publication-title: J Biol Chem doi: 10.1074/jbc.M204131200 – volume: 275 start-page: 22986 year: 2000 ident: 2019041200062926400_R4 article-title: FXXLF and WXXLF sequences mediate the NH2-terminal interaction with the ligand binding domain of the androgen receptor. publication-title: J Biol Chem doi: 10.1074/jbc.M002807200 – volume: 103 start-page: 7789 year: 2006 ident: 2019041200062926400_R37 article-title: Progression of prostate cancer by synergy of AKT with genotropic and nongenotropic actions of the androgen receptor. publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.0602567103 – volume: 145 start-page: 134 year: 2004 ident: 2019041200062926400_R17 article-title: An androgen-dependent upstream enhancer is essential for high levels of probasin gene expression. publication-title: Endocrinology doi: 10.1210/en.2003-0568 – volume: 128 start-page: 309 year: 2007 ident: 2019041200062926400_R41 article-title: FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis. publication-title: Cell doi: 10.1016/j.cell.2006.12.029 – volume: 19 start-page: 1182 year: 1999 ident: 2019041200062926400_R42 article-title: The Angelman syndrome-associated protein, E6-AP, is a coactivator for the nuclear hormone receptor superfamily. publication-title: Mol Cell Biol doi: 10.1128/MCB.19.2.1182 – volume: 66 start-page: 6998 year: 2006 ident: 2019041200062926400_R23 article-title: FOXO1A is a candidate for the 13q14 tumor suppressor gene inhibiting androgen receptor signaling in prostate cancer. publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-06-0411 – reference: 7789761 - Genetics. 1995 Apr;139(4):1567-83 – reference: 10454556 - Mol Cell Biol. 1999 Sep;19(9):6085-97 – reference: 15514032 - Mol Endocrinol. 2005 Feb;19(2):350-61 – reference: 12727974 - J Clin Endocrinol Metab. 2003 May;88(5):2185-93 – reference: 17277772 - Nat Cell Biol. 2007 Mar;9(3):347-53 – reference: 10564676 - J Natl Cancer Inst. 1999 Nov 17;91(22):1922-32 – reference: 16288288 - Oncogene. 2005 Nov 14;24(50):7410-25 – reference: 17202144 - J Biol Chem. 2007 Mar 9;282(10):7329-38 – reference: 11278645 - J Biol Chem. 2001 Jun 8;276(23):20444-50 – reference: 10343290 - J Mol Endocrinol. 1999 Jun;22(3):313-25 – reference: 17616663 - Cancer Res. 2007 Jul 1;67(13):6083-91 – reference: 9214605 - Carcinogenesis. 1997 Jun;18(6):1215-23 – reference: 12914534 - J Mol Endocrinol. 2003 Aug;31(1):169-83 – reference: 12351634 - J Biol Chem. 2002 Dec 6;277(49):47928-37 – reference: 16849544 - Cancer Res. 2006 Jul 15;66(14):6998-7006 – reference: 9885576 - Mol Cell. 1998 Dec;2(6):887-93 – reference: 14504652 - Cell Mol Life Sci. 2003 Aug;60(8):1613-22 – reference: 7979245 - Annu Rev Biochem. 1994;63:451-86 – reference: 10557100 - Oncogene. 1999 Nov 1;18(45):6094-103 – reference: 7706276 - J Biol Chem. 1995 Mar 31;270(13):7341-6 – reference: 16682621 - Proc Natl Acad Sci U S A. 2006 May 16;103(20):7789-94 – reference: 10051603 - Proc Natl Acad Sci U S A. 1999 Mar 2;96(5):2110-5 – reference: 8422609 - CA Cancer J Clin. 1993 Jan-Feb;43(1):7-26 – reference: 17923482 - J Biol Chem. 2007 Dec 7;282(49):35583-93 – reference: 12589022 - Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2226-30 – reference: 10077001 - Mol Endocrinol. 1999 Mar;13(3):440-54 – reference: 12482965 - Mol Cell Biol. 2003 Jan;23(1):104-18 – reference: 15131260 - Mol Endocrinol. 2004 Aug;18(8):2011-23 – reference: 12714702 - Mol Endocrinol. 2003 Jul;17(7):1296-314 – reference: 1775129 - Mol Endocrinol. 1991 Oct;5(10):1396-404 – reference: 17254969 - Cell. 2007 Jan 26;128(2):309-23 – reference: 12015328 - J Biol Chem. 2002 Aug 9;277(32):29304-14 – reference: 14522255 - Cancer Cell. 2003 Sep;4(3):209-21 – reference: 14500578 - Endocrinology. 2004 Jan;145(1):134-48 – reference: 11931767 - Mol Cell. 2002 Mar;9(3):601-10 – reference: 12855809 - Science. 2003 Jul 11;301(5630):215-8 – reference: 14755679 - J Cell Biochem. 2004 Feb 15;91(3):483-90 – reference: 9891052 - Mol Cell Biol. 1999 Feb;19(2):1182-9 – reference: 11376111 - Mol Endocrinol. 2001 Jun;15(6):923-35 – reference: 8530400 - J Biol Chem. 1995 Dec 15;270(50):29983-90 – reference: 15843149 - Biol Chem. 2005 Jan;386(1):69-74 – reference: 18239123 - Science. 2008 Feb 1;319(5863):611-3 – reference: 10454563 - Mol Cell Biol. 1999 Sep;19(9):6164-73 – reference: 16751106 - Cell. 2006 Jun 2;125(5):987-1001 – reference: 11923463 - Mol Endocrinol. 2002 Apr;16(4):647-60 – reference: 12150827 - Cancer Cell. 2002 Jul;2(1):81-91 – reference: 11353774 - J Biol Chem. 2001 Jul 27;276(30):27907-12 – reference: 9368054 - J Biol Chem. 1997 Nov 21;272(47):29821-8 – reference: 10816582 - J Biol Chem. 2000 Jul 28;275(30):22986-94 |
SSID | ssj0014581 |
Score | 2.188097 |
Snippet | Abstract
FoxO (mammalian forkhead subclass O) proteins are transcription factors acting downstream of the PTEN (phosphatase and tensin homolog deleted on... FoxO (mammalian forkhead subclass O) proteins are transcription factors acting downstream of the PTEN (phosphatase and tensin homolog deleted on chromosome 10)... |
SourceID | pubmedcentral proquest pubmed crossref oup |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 213 |
SubjectTerms | Animals Cell Line Forkhead Transcription Factors - genetics Forkhead Transcription Factors - metabolism Gene Expression Regulation Humans Protein Isoforms - genetics Protein Isoforms - metabolism Protein Structure, Tertiary PTEN Phosphohydrolase - genetics PTEN Phosphohydrolase - metabolism Receptors, Androgen - chemistry Receptors, Androgen - genetics Receptors, Androgen - metabolism RNA Interference src-Family Kinases - genetics src-Family Kinases - metabolism Transcription, Genetic |
Title | FoxO1 Mediates PTEN Suppression of Androgen Receptor N- and C-Terminal Interactions and Coactivator Recruitment |
URI | https://www.ncbi.nlm.nih.gov/pubmed/19074551 https://www.proquest.com/docview/66855343 https://pubmed.ncbi.nlm.nih.gov/PMC2646622 |
Volume | 23 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLZgSIgXBBuXcvUD8FJ5WmLXSR7H1GlCaweilfoW2Y4zIrVp1SZI8Os5viRN0CYuL1HruE7V7-vJOc53zkHoXZjFWa51REIWU8J0IImgUhElIxVQbSqGWbXFlF_M2afFaLGX29rskkoeq5835pX8D6owBriaLNl_QLZdFAbgNeALR0AYjn-FMdw6rgKX_GG2Tz_PxtPhrt54bat1BIUpSAALDMGy6Q0E2MMpsQ8MzojXwSxtyYitS3DY-Tw38-67icfN57Z1UbUCmab7U9NWd6jLbA2mx-3PG4f1o1hWRaPfnWTHnc2GiXVVvxT1prljGurUVuini1YcVDjlcHmd7wcNZXdO2fvVND726txmwyJpNM4duxYTMBtJ1wi7pGNPtrBnUemNlh5CVYBnZSudGjmeq9vZL6g9vUrP55eX6Wy8mN1F90KIJGw--KJVAQVsZPvYtt_J50aYxKbu2j2vpZcJ2QlIftfVdhyV2SP00EcY-NTR5TG6o8tDdHRaApqrH_gDtppfC9Yhuj_x0oojtLZkwg2ZsCET7pAJr3PckAk3ZMJTYgbxnky4SyZ7rkMm3CHTEzQ_H8_OLojvxkEUC1hFZJwrIaNA5FJTFqowkCKj-YlkjAtFuYpUEmcsCzjXI60gkJc0kInkiVYZE5w-RQflutTPEQa3XwimpBaCMnaSx3kgZZQorsB9zFU2QMPm106VL1VvOqYsUxOyAjbpSvv-qYDNAL1vZ29ciZZb5mEA7rYpxE1526Cagpk1z85Eqdf1LuU8Ho0oowP0zGG8X8dsL0HcMUBRD_12ging3j9TFt9sIXcIRjgPwxd_vOpL9GD_T3qFDqptrV-DM1zJN5bOvwAR0Lm8 |
linkProvider | Geneva Foundation for Medical Education and Research |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=FoxO1+mediates+PTEN+suppression+of+androgen+receptor+N-+and+C-terminal+interactions+and+coactivator+recruitment&rft.jtitle=Molecular+endocrinology+%28Baltimore%2C+Md.%29&rft.au=Ma%2C+Qiuping&rft.au=Fu%2C+Wei&rft.au=Li%2C+Pengfei&rft.au=Nicosia%2C+Santo+V&rft.date=2009-02-01&rft.issn=0888-8809&rft.volume=23&rft.issue=2&rft.spage=213&rft_id=info:doi/10.1210%2Fme.2008-0147&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0888-8809&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0888-8809&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0888-8809&client=summon |